Statistics for Abivax SA (id:10801 ABVX)

Valuation metrics

Market cap

509.55M

Enterprise value

383.72M

Trailing P/E (ttm)

-2.34

Forward P/E

-5.33

PEG ratio

-5.33

Price/Sales (ttm)

56.42

Price/Book (mrq)

3.90

Enterprise Value/Revenue

42.49

Enterprise Value/EBITDA

-2.26

Overview

Shares outstanding

62.92M

Float

25.19M

Shares short

% Held by insiders

0.02%

% Held by institutions

0.50%

Average volume (10 days)

29.05K

Average volume (90 days)

Price summary

52-Week low

7.59

52-Week high

15.42

52-Week change

-10.57%

Beta

1.42

50-Day moving average

9.32

200-Day moving average

11.65

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

0.00%

Operating margin

-1,178.84%

Operational effectiveness

Return on assets

-46.69%

Return on equity

-171.46%

Income statement

Revenue (ttm)

0.16

Revenue per share (ttm)

0.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-169,872,000.00

Net income to common (ttm)

-177,424,992.00

Diluted EPS (ttm)

-3.43

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

222.32M

Total cash per share (mrq)

3.53

Total debt (mrq)

113.36M

Total Debt/Equity (mrq)

89.64

Current ratio (mrq)

303.90%

Book value per share (mrq)

2.01

Cash flow

Cash flow statement

-154,706,000.00

Levered free cash flow (LFCF)

-89,297,752.00